
AI-powered clinical assistant for UK healthcare professionals
What are the common complications of systemic vasculitis that I should monitor for in my patients?
Answer
Guideline-Aligned (High Confidence)
Generated by iatroX. Developer: Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner).
Last reviewed: 16 August 2025
Common complications of systemic vasculitis to monitor in patients include:
- Organ ischemia and infarction: Due to vessel inflammation and occlusion, leading to tissue damage in affected organs such as kidneys, lungs, and peripheral nerves 1 (Moosig et al., 2009).
- Renal impairment: Particularly in small-vessel vasculitis like ANCA-associated vasculitis, which can cause rapidly progressive glomerulonephritis and chronic kidney disease 1 (Villa-Forte et al., 2010).
- Neurological complications: Peripheral neuropathy and mononeuritis multiplex from nerve ischemia are common and require monitoring 1 (Moosig et al., 2009).
- Respiratory involvement: Pulmonary hemorrhage and interstitial lung disease can occur, especially in granulomatosis with polyangiitis, necessitating vigilance for respiratory symptoms 1 (Villa-Forte et al., 2010).
- Cardiovascular complications: Including myocarditis, pericarditis, and increased risk of accelerated atherosclerosis due to chronic inflammation 1 (Moosig et al., 2009).
- Infections: Secondary to immunosuppressive therapy used in vasculitis management, increasing susceptibility to opportunistic infections 1 (Villa-Forte et al., 2010).
- Medication-related toxicity: Monitoring for adverse effects of corticosteroids and cytotoxic agents is essential 1 (Villa-Forte et al., 2010).
Imaging modalities can assist in detecting vascular inflammation and complications early, supporting clinical monitoring (Troum et al., 2025).
Key References
- NG100 - Rheumatoid arthritis in adults: management
- NG130 - Ulcerative colitis: management
- NG239 - Vitamin B12 deficiency in over 16s: diagnosis and management
- (Moosig et al., 2009): [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].
- (Villa-Forte et al., 2010): European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis.
- (Troum et al., 2025): Imaging in vasculitis.
Related Questions
Finding similar questions...